Total Payments
$12,651
2024 Payments
$22.35
Companies
14
Transactions
34
Medicare Patients
530
Medicare Billing
$97,771
Payment Breakdown by Category
Travel$11,205 (88.6%)
Food & Beverage$1,424 (11.3%)
Education$21.97 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $11,205 | 5 | 88.6% |
| Food and Beverage | $1,424 | 28 | 11.3% |
| Education | $21.97 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Company LTD | $11,205 | 5 | $0 (2017) |
| Baxter Healthcare | $655.77 | 7 | $0 (2024) |
| Amgen Inc. | $205.51 | 4 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $194.69 | 6 | $0 (2022) |
| Relypsa, Inc. | $144.87 | 2 | $0 (2018) |
| Fresenius USA Marketing, Inc. | $48.77 | 2 | $0 (2023) |
| Travere Therapeutics, Inc. | $39.81 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $30.83 | 1 | $0 (2019) |
| BTG International, Inc. | $25.24 | 1 | $0 (2023) |
| Ardelyx, Inc. | $24.23 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.35 | 1 | Baxter Healthcare ($22.35) |
| 2023 | $136.02 | 5 | Travere Therapeutics, Inc. ($39.81) |
| 2022 | $86.42 | 1 | Otsuka America Pharmaceutical, Inc. ($86.42) |
| 2021 | $32.65 | 2 | SANOFI-AVENTIS U.S. LLC ($17.50) |
| 2020 | $97.59 | 1 | BAXTER HEALTHCARE ($97.59) |
| 2019 | $119.15 | 4 | Amgen Inc. ($64.32) |
| 2018 | $588.08 | 10 | BAXTER HEALTHCARE ($217.24) |
| 2017 | $11,569 | 10 | Daiichi Sankyo Company LTD ($11,205) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/19/2024 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Renal | ||||||
| 12/06/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $39.81 | General |
| 03/22/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $21.97 | General |
| Category: NEPHROLOGY | ||||||
| 03/16/2023 | BTG International, Inc. | VORAXAZE (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 02/27/2023 | Fresenius USA Marketing, Inc. | LIBERTY SELECT CYCLER (Device), KORSUVA | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Nephrology | ||||||
| 11/16/2022 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $86.42 | General |
| 09/17/2021 | SANOFI-AVENTIS U.S. LLC | CABLIVI (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Hematology | ||||||
| 09/16/2021 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.15 | General |
| 01/23/2020 | BAXTER HEALTHCARE | Renal - PrisMax System (Device) | Food and Beverage | In-kind items and services | $97.59 | General |
| Category: Renal | ||||||
| 11/12/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.83 | General |
| 07/10/2019 | Fresenius USA Marketing, Inc. | Critline - Monitors (Device), Velphoro | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: System, Hemodialysis, Access Recirculation Monitoring | ||||||
| 02/07/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $34.97 | General |
| Category: Cardiology | ||||||
| 01/09/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Cardiology | ||||||
| 11/05/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Hyperkalemia | ||||||
| 11/05/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEPHROLOGY | ||||||
| 10/09/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: NEPHROLOGY | ||||||
| 09/20/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $124.53 | General |
| Category: Hyperkalemia | ||||||
| 08/23/2018 | Amgen Inc. | Aranesp (Biological), XGEVA | Food and Beverage | In-kind items and services | $96.19 | General |
| Category: Nephrology | ||||||
| 07/17/2018 | BAXTER HEALTHCARE | Renal - CRRT (Device) | Food and Beverage | In-kind items and services | $122.65 | General |
| Category: Renal | ||||||
| 04/26/2018 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Oncology | ||||||
| 04/13/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: NEPHROLOGY | ||||||
| 01/24/2018 | BAXTER HEALTHCARE | Renal - CRRT (Device) | Food and Beverage | In-kind items and services | $94.59 | General |
| Category: Renal | ||||||
| 01/23/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: NEPHROLOGY | ||||||
| 09/13/2017 | BAXTER HEALTHCARE | Renal - CRRT (Device) | Food and Beverage | In-kind items and services | $91.37 | General |
| Category: Renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 79 | 132 | $41,291 | $12,119 |
| 2022 | 3 | 127 | 234 | $86,655 | $22,144 |
| 2021 | 3 | 122 | 250 | $94,445 | $23,678 |
| 2020 | 3 | 202 | 391 | $140,863 | $39,830 |
Total Patients
530
Total Services
1,007
Medicare Billing
$97,771
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 74 | $21,182 | $7,039 | 33.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 40 | $9,110 | $2,558 | 28.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $10,999 | $2,523 | 22.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 75 | 172 | $48,676 | $14,309 | 29.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 42 | $25,784 | $6,643 | 25.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 11 | 20 | $12,195 | $1,191 | 9.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 69 | 179 | $50,657 | $14,993 | 29.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 39 | 39 | $23,414 | $6,403 | 27.3% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 14 | 32 | $20,374 | $2,282 | 11.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 106 | 281 | $79,523 | $24,060 | 30.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 80 | 83 | $44,883 | $13,836 | 30.8% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2020 | 16 | 27 | $16,457 | $1,933 | 11.7% |
About Dr. Farhad Danesh, MD
Dr. Farhad Danesh, MD is a Nephrology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1740312412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Farhad Danesh, MD has received a total of $12,651 in payments from pharmaceutical and medical device companies, with $22.35 received in 2024. These payments were reported across 34 transactions from 14 companies. The most common payment nature is "Travel and Lodging" ($11,205).
As a Medicare-enrolled provider, Danesh has provided services to 530 Medicare beneficiaries, totaling 1,007 services with total Medicare billing of $97,771. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Houston, TX
- Active Since 03/09/2007
- Last Updated 05/15/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1740312412
Products in Payments
- Benicar (Drug) $11,205
- Renal - CRRT (Device) $415.46
- Veltassa (Drug) $144.87
- Renal - Prismaflex System (Device) $120.37
- Renal - PrisMax System (Device) $97.59
- Aranesp (Biological) $96.19
- SAMSCA (Drug) $84.74
- Repatha (Biological) $64.32
- XGEVA (Biological) $45.00
- VORAXAZE (Drug) $25.24
- LIBERTY SELECT CYCLER (Device) $24.77
- IBSRELA (Drug) $24.23
- Critline - Monitors (Device) $24.00
- ABILIFY MAINTENA (Drug) $23.49
- Renal - Acute (Device) $22.35
- JYNARQUE (Drug) $22.03
- RAYALDEE (Drug) $21.97
- CABLIVI (Biological) $17.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Houston
Sreedhar Mandayam, M.d, M.D
Nephrology — Payments: $789,657
Nephrology $789,657
Dr. Christopher Kwoh, M.d, M.D
Nephrology — Payments: $420,843
Nephrology $420,843
Dr. Maher Bishara, M.d, M.D
Nephrology — Payments: $119,839
Nephrology $119,839
Rajeev Raghavan, Md, MD
Nephrology — Payments: $119,615
Nephrology $119,615
Dr. Horacio Adrogue, Md, MD
Nephrology — Payments: $102,891
Nephrology $102,891
Dr. Jaya Kala, Md, MD
Nephrology — Payments: $81,881
Nephrology $81,881